We are live on ! Find out more
EXAS

Exact Sciences

Delisted

EXAS was delisted on the 20th of March, 2026.

711 hedge funds and large institutions have $17.9B invested in Exact Sciences in 2025 Q4 according to their latest regulatory filings, with 254 funds opening new positions, 152 increasing their positions, 215 reducing their positions, and 98 closing their positions.

New
Increased
Maintained
Reduced
Closed

925% more funds holding in top 10

Funds holding in top 10: 441 (+37)

159% more first-time investments, than exits

New positions opened: 254 | Existing positions closed: 98

84% more capital invested

Capital invested by funds: $9.7B → $17.9B (+$8.18B)

75% more call options, than puts

Call options by funds: $359M | Put options by funds: $205M

25% more funds holding

Funds holding: 569711 (+142)

0.64% less ownership

Funds ownership: 93.65%93.01% (-0.64%)

29% less repeat investments, than reductions

Existing positions increased: 152 | Existing positions reduced: 215

Holders
711
Holders Change
+142
Holders Change %
+24.96%
% of All Funds
8.63%
Holding in Top 10
41
Holding in Top 10 Change
+37
Holding in Top 10 Change %
+925%
% of All Funds
0.5%
New
254
Increased
152
Reduced
215
Closed
98
Calls
$359M
Puts
$205M
Net Calls
+$154M
Net Calls Change
+$124M
Name Holding Trade Value Shares
Change
Change in
Stake
GITFIT
751
Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)
Poland
-$1.53M -28,000 Closed
CCIA
752
Campbell & Co Investment Adviser
Maryland
-$1.43M -26,112 Closed
WP
753
Waycross Partners
Kentucky
-$1.37M -25,000 Closed
GIP
754
Granite Investment Partners
California
-$1.2M -21,944 Closed
QIM
755
Quantitative Investment Management
Virginia
-$1.19M -21,732 Closed
OAM
756
OP Asset Management
-$1.09M -19,892 Closed
HCA
757
Harbor Capital Advisors
Illinois
-$1.02M -18,705 Closed
AV
758
ASR Vermogensbeheer
Netherlands
-$927K -16,948 Closed
EP
759
Edgestream Partners
New Jersey
-$891K -16,284 Closed
FGP
760
Freestone Grove Partners
California
-$842K -15,384 Closed
Robeco Institutional Asset Management
761
Robeco Institutional Asset Management
Netherlands
-$796K -14,548 Closed
SAM
762
Silvercrest Asset Management
New York
-$771K -14,099 Closed
LAM
763
LECAP Asset Management
United Kingdom
-$679K -12,413 Closed
GCM
764
Graham Capital Management
Connecticut
-$604K -11,039 Closed
NICM
765
Neo Ivy Capital Management
New York
-$600K -10,960 Closed
QPW
766
Quantum Private Wealth
Florida
-$505K -9,238 Closed
OBAM
767
ODDO BHF Asset Management
France
-$503K -9,189 Closed
MGIA
768
Moneta Group Investment Advisors
Missouri
-$489K -8,934 Closed
BJL
769
Brighton Jones LLC
Washington
-$487K -8,893 Closed
AIM
770
Aigen Investment Management
New York
-$416K -7,608 Closed
AV
771
Alamea Verwaltungs
New Jersey
-$395K -7,222 Closed
MYLI
772
Meiji Yasuda Life Insurance
Japan
-$367K -6,707 Closed
MG
773
Marex Group
-$358K -6,538 Closed
GLA
774
Great Lakes Advisors
Illinois
-$354K -6,463 Closed
FRM
775
Fox Run Management
Connecticut
-$305K -5,581 Closed

EXAS Hedge Fund Activity: Q4 2025 in Review

711 of the 8,238 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q4 2025, worth a combined $17.9B — up 84% from $9.7B a quarter earlier.

Buyers outnumbered sellers: 254 funds opened new EXAS positions and 98 closed out — a net gain of 156 holders — while 152 added to existing stakes and 215 trimmed.

The largest buyer was HBK Investments, opening a new position worth an estimated $614M. The largest seller was Fidelity Investments, cutting an estimated $1.41B.

  • 711 institutional investors held Exact Sciences (EXAS) as of Q4 2025, up from 569 in Q3 2025.
  • Funds reported $17.9B of Exact Sciences stock for Q4 2025, up 84% quarter-over-quarter.
  • 254 funds opened new Exact Sciences positions in Q4 2025 and 98 closed out, a net change of +156 holders.
  • The largest Exact Sciences buyer in Q4 2025 was HBK Investments, an estimated $614M added.
  • The largest Exact Sciences seller in Q4 2025 was Fidelity Investments, an estimated $1.41B sold.

Based on aggregated 13F filings for Q4 2025.